Key Highlights

  • Sales increased 51% to $308.6 million, adding $103.7 million year over year.
  • Net income reached $18.4 million, compared with $0.2 million in the prior-year quarter.
  • Adjusted EBITDA of about $61 million rose more than 6% and exceeded the top of guidance.
  • The company raised its 2026 outlook following the third-quarter results.

Ecovyst (NYSE:ECVT), a provider of regenerated and virgin sulfuric acid and sulfur dioxide derivatives, reported third-quarter 2026 results for the period ended September 30, 2026. Sales rose 51%, a gain that reflects the June 30 Acquisition of the Calabrian sulfur dioxide and related Derivatives business. The company also reported higher net income, adjusted EBITDA above the top of its guidance range, and an increase to its 2026 outlook.

Separating the acquisition effect from organic growth matters for judging the quarter. Because the Calabrian Business was added only on June 30, its contribution in the third quarter reflects a full period of operations that did not exist in the prior-year base. The release does not split the $103.7 million increase between acquired and existing operations, so readers must rely on the company's commentary for the organic trend.

Sales Growth and the Calabrian Acquisition

Third-quarter sales reached $308.6 million, an increase of $103.7 million from $204.9 million in the prior-year quarter. The release says reported results for the quarter included the Calabrian business, which the company acquired on June 30, 2026. Acquired operations add to Revenue from the date of closing, so the growth figure is not a measure of organic Demand alone.

The company completed the sale of its Advanced Materials and Catalysts business on December 31, 2025. That business, along with the company's Investment in Zeolyst, is reported as discontinued operations for all periods, which means the continuing operations figures compare only the businesses the company kept.

Sulfuric acid is a basic industrial chemical used in refining, metal processing and mining, so the company's volumes are closely tied to the operating rates of those industries. Regenerated acid, which the company recovers from spent acid, depends on refinery activity, while virgin acid serves Mining and other applications. The release's description of growth across both product lines suggests that demand was broad enough to support higher volumes in each.

Demand Drivers and Volumes

Chief executive Kurt Bitting said higher refining margins and increased export demand drove year-over-year growth in regenerated sulfuric acid volumes and sales. Regenerated acid is used in refinery operations, so demand for it tends to track activity at refineries and the Economics of refining.

Virgin sulfuric acid sales also increased, which Bitting linked to mining activity. Because the company serves several end markets, the release describes growth across refining and mining rather than in a single sector.

Net income of $18.4 million on sales of $308.6 million implies that the company's Net Income Margin of 6.0% is well above the prior-year level, which was close to zero. Because the acquisition added revenue and costs at the same time, the margin figure reflects the combined effect of the new business and the existing operations, and the release does not separate the two.

Earnings and Adjusted EBITDA

Net income for the quarter was $18.4 million, with a net income margin of 6.0%, compared with $0.2 million a year earlier. The difference reflects the higher sales base and the operating results of the continuing businesses, although the release also includes items that affect the GAAP figure.

Adjusted EBITDA was about $61 million, up more than 6% from the prior year and above the high end of the company's guidance range, according to Bitting. The release says the company's adjusted figure is a non-GAAP measure, and the reconciliation shows how it is calculated.

The raised 2026 outlook matters most for investors who want to know whether the third-quarter results are a one-time lift or a change in the run-rate of the business. The release does not give revised figures in the highlights, so the magnitude of the increase must be read from the outlook table.

Raised 2026 Outlook

Ecovyst raised its 2026 outlook following the third quarter. The company's update follows a quarter in which both sales and adjusted EBITDA exceeded expectations, and it signals management's view that the rest of the year will be better than previously forecast. The release provides the revised figures in its outlook section.

Because the outlook now incorporates a full quarter of the Calabrian business, comparisons with the original 2026 figures reflect both the acquisition and the operating trends of the existing business. Readers should separate those two effects when evaluating the raised guidance.

Investors will watch whether the company can keep adjusted EBITDA above its guidance range in future quarters, and whether the Calabrian business continues to integrate smoothly into the reported results. The raised 2026 outlook sets a higher bar for the rest of the year, so subsequent quarters will test management's assumptions.

Outlook

Ecovyst's third-quarter report shows a sharp increase in sales that is partly acquisition-driven, a sizable swing to positive net income and adjusted EBITDA ahead of guidance. The company's ability to sustain refining and mining demand after the acquisition will determine whether the higher sales base can hold in future quarters.